Medlive Technology Co., Ltd. (HK:2192) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medlive Technology Co., Ltd. has scheduled a board meeting for August 27, 2024, where they will discuss the company’s interim results for the first half of the year and consider the declaration of an interim dividend. The announcement was made by Chairwoman and CEO Tian Liping, indicating the company’s proactive approach to financial planning and shareholder communication.
For further insights into HK:2192 stock, check out TipRanks’ Stock Analysis page.